Genetic variants in haem oxygenase-1 and endothelial nitric oxide synthase influence the extent and evolution of coronary artery atherosclerosis

Folia Biologica (Czech Republic)

Volumn 57, Issue 5, 2011, Pages 182-190

  Kral A ^a   Kovarnik T ^a   Kralik L ^a   Skalicka H ^a   Horak J ^a   Mintz, G S ^b   Uhrova J ^c   Sonka, M ^a   Wahle, A ^d   Downe, R ^d   Aschermann, M ^a   Martasek P ^a   Linhart, A ^a  

^a CHARLES UNIVERSITY   (Czech Republic)

^b CARDIOVASCULAR RESEARCH FOUNDATION   (United States)

^c CHARLES UNIVERSITY   (Czech Republic)

^d IA United States   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ATORVASTATIN; ENDOTHELIAL NITRIC OXIDE SYNTHASE; EZETIMIBE; FLUINDOSTATIN; GLYCERYL TRINITRATE; HEME OXYGENASE 1; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; SIMVASTATIN;

ADULT; AGED; ANGIOCARDIOGRAPHY; ARTICLE; ATHEROMA; CORONARY ARTERY ATHEROSCLEROSIS; FEMALE; FOLLOW UP; GENETIC POLYMORPHISM; GENETIC VARIABILITY; GENOTYPE; HOMOZYGOTE; HUMAN; INTRAVASCULAR ULTRASOUND; MAJOR CLINICAL STUDY; MALE; PROMOTER REGION; CORONARY ARTERY DISEASE; CORONARY BLOOD VESSEL; ECHOGRAPHY; ENDOSCOPIC ECHOGRAPHY; ENDOTHELIUM CELL; ENZYMOLOGY; GENETICS; MIDDLE AGED; PATHOLOGY;

AGED; CORONARY ANGIOGRAPHY; CORONARY ARTERY DISEASE; CORONARY VESSELS; ENDOTHELIAL CELLS; FEMALE; GENETIC VARIATION; GENOTYPE; HEME OXYGENASE-1; HUMANS; MALE; MIDDLE AGED; NITRIC OXIDE SYNTHASE TYPE III; POLYMORPHISM, GENETIC; ULTRASONOGRAPHY, INTERVENTIONAL;

EID: 84861825407     PISSN: 00155500     EISSN: 25337602     Source Type: Journal    
DOI: None     Document Type: Article

References (39)

1. Abraham, N. G., Kappas, A. (2008) Pharmacological and clinical aspects of heme oxygenase. Pharmacol. Rev. 60, 79-27.
2. Chen, J. C., Huang, K. C., Lin, W. W. (2006) HMG-CoA reductase inhibitors upregulate heme oxygenase-1 expression in murine RAW264.7 macrophages via ERK, p38 MAPK and protein kinase G pathways. Cell. Signal. 18, 32-39.
3. Cheng, C., Noordeloos, A. M., Jeney, V., Soares, M. P., Moll, F., Pasterkamp, G., Serruys, P. W, Duckers, H. J. (2009) Heme oxygenase 1 determines atherosclerotic lesion pro-gression into a vulnerable plaque. Circulation 119, 3017-3027.
4. Colombo, M. G., Paradossi, U., Andreassi, M. G., Botto, N., Manfredi, S., Masetti, S., Biagini, A., Clerico, A. (2003) Endothelial nitric oxide synthase gene polymorphisms and risk of coronary artery disease. Clin. Chem. 49, 389-395.
5. Dulak, J., Loboda, A., Jazwa, A., Zagorska, A., Dorler, J., Alber, H., Dichtl, W., Weidinger, F., Frick, M., Jozkowicz, A. (2005) Atorvastatin affects several angiogenic mediators in human endothelial cells. Endothelium 12, 233-241.
6. Fairchild, T. A., Fulton, D., Fontana, J. T., Gratton, J. P., McCabe, T. J., Sessa, W. C. (2001) Acidic hydrolysis as a mechanism for the cleavage of the Glu(298) Asp variant of human endothelial nitric-oxide synthase. J. Biol. Chem. 276, 26674-26679.
7. Forstermann, U. (2010) Nitric oxide and oxidative stress in vascular disease. Pflugers Arch. 459, 923-939.
8. Garcia-Garcia, H. M., Mintz, G. S., Lerman, A., Vince, D. G., Margolis, M. P., van Es, G. A., Morel, M. A., Nair, A., Virmani, R., Burke, A. P., Stone, G. W., Serruys, P. W. (2009) Tissue characterisation using intravascular radiofrequency data analysis: recommendations for acquisition, analysis, interpretation and reporting. EuroIntervention 5, 177-189.
9. Gardemann, A., Lohre, J., Cayci, S., Katz, N., Tillmanns, H., Haberbosch, W. (2002) The T allele of the missense Glu(298)Asp endothelial nitric oxide synthase gene polymorphism is associated with coronary heart disease in younger individuals with high atherosclerotic risk profile. Atherosclerosis 160, 167-175.
10. Idriss, N. K., Blann, A. D., Lip, G. Y. (2008) Hemoxygenase-1 in cardiovascular disease. J. Am. Coll. Cardiol. 52, 971-978.
11. Jaramillo, P. C., Lanas, C., Lanas, F., Salazar, L. A. (2010) Polymorphisms of the NOS3 gene in Southern Chilean subjects with coronary artery disease and controls. Clin. Chim. Acta. 411, 258-262.
12. Juan, S. H., Lee, T. S., Tseng, K. W., Liou, J. Y., Shyue, S. K., Wu, K. K., Chau, L. Y. (2001) Adenovirus-mediated heme oxygenase-1 gene transfer inhibits the development of atherosclerosis in apolipoprotein E-deficient mice. Circulation 104, 1519-1525.
13. Kaneda, H., Ohno, M., Taguchi, J., Togo, M., Hashimoto, H., Ogasawara, K., Aizawa, T., Ishizaka, N., Nagai, R. (2002) Heme oxygenase-1 gene promoter polymorphism is associated with coronary artery disease in Japanese patients with coronary risk factors. Arterioscler. Thromb. Vasc. Biol. 22, 1680-1685.
14. Kauser, K., da Cunha, V., Fitch, R., Mallari, C., Rubanyi, G. M. (2000) Role of endogenous nitric oxide in progression of atherosclerosis in apolipoprotein E-deficient mice. Am. J. Physiol. Heart Circ. Physiol. 278, H1679-1685.
15. Kawamura, K., Ishikawa, K., Wada, Y., Kimura, S., Matsumoto, H., Kohro, T., Itabe, H., Kodama, T., Maruyama, Y. (2005) Bilirubin from heme oxygenase-1 attenuates vascular endothelial activation and dysfunction. Arterioscler. Thromb. Vasc. Biol. 25, 155-160.
16. Kuhlencordt, P. J., Gyurko, R., Han, F., Scherrer-Crosbie, M., Aretz, T. H., Hajjar, R., Picard, M. H., Huang, P. L. (2001) Accelerated atherosclerosis, aortic aneurysm formation, and ischemic heart disease in apolipoprotein E/endothelial nitric oxide synthase double knockout mice. Circulation 104, 448-454.
17. Kushida, T., LiVolti, G., Goodman, A. I., Abraham, N. G. (2002) TNF-α-mediated cell death is attenuated by retrovirus delivery of human heme oxygenase-1 gene into human microvessel endothelial cells. Transplant. Proc. 34, 2973-2978.
18. Larsen, K., Cheng, C., Duckers, H. J. (2010) Regulation of vulnerable plaque development by the heme oxygenase/carbon monoxide system. Trends Cardiovasc. Med. 20, 58-65.
19. Li, J., Wu, X., Li, X., Feng, G., He, L., Shi, Y. (2010) The endothelial nitric oxide synthase gene is associated with coronary artery disease: a meta-analysis. Cardiology 116, 271-278.
20. Mintz, G. S., Maehara, A. (2009) Serial intravascular ultrasound assessment of atherosclerosis progression and regression. State-of-the-art and limitations. Circ. J. 73, 1557-1560.
21. Morita, T., Mitsialis, S. A., Hioke, H., Liu, Y., Kourembanas, S. (1997) Carbon monooxide controls the proliferation of hypoxic smooth muscle cells. J. Biol. Chem. 272, 32804-32809.
22. Morita, T. (2005) Heme oxygenase and atherosclerosis. Arterioscler. Thromb. Vasc. Biol. 25, 1786-1795.
23. Naber, C. K., Baumgart, D., Altmann, C., Siffert, W., Erbel, R., Heusch, G. (2001) ENOS 894T allele and coronary blood flow at rest and during adenosine-induced hyperemia. Am. J. Physiol. Heart Circ. Physiol. 5, H1908-1912.
24. Nissen, S. E., Nicholls, S. J., Sipahi, I., Libby, P., Raichlen, J. S., Ballantyne, C. M. (2006) Effect of very high-intensity statin therapy on regression of coronary atherosclerosis: The ASTEROID trial. J. Am. Med. Assoc. 295, 1556-1565.
25. Pfohl, M., Athanasiadis, A., Koch, M., Clemens, P., Benda, N., Haring, H. U., Karsch, K. R. (1998) Insertion/deletion polymorphism of the angiotensin I-converting enzyme gene is associated with coronary artery plaque calcification as assessed by intravascular ultrasound. J. Am. Coll. Cardiol. 31, 987-991.
26. Pinderski, L. J., Fischbein, M. P., Subbanagounder, G., Fishbein, M. C., Kubo, N., Cheroutre, H., Curtiss, L. K., Berliner, J. A., Boisvert, W. A. (2002) Overexpression of interleukin-10 by activated T lymphocytes inhibits atherosclerosis in LDL receptor-deficient mice by altering lymphocyte and macrophage phenotypes. Circ. Res. 90, 1064-1071.
27. Rodriguez, A. I., Gangopadhyay, A., Kelley, E. E., Pagano, P. J., Zuckerbraun, B. S., Bauer, P. M. (2010) HO-1 and CO decrease platelet derived growth factor-induced vascular smooth muscle cell migration via inhibition of Nox1. Arterioscler. Thromb. Vasc. Biol. 30, 98-104.
28. Rodriguez-Granillo, G. A., Aoki, J., Ong, A. T., Valgimigli, M., Van Mieghem, C. A., Regar, E., McFadden, E., De Feyter, P., Serruys, P. W. (2005) Methodological considerations and approach to cross-technique comparisons using in vivo coronary plaque characterization based on intravascular radiofrequency data anlaysis: insights from the integrated Biomarker and Imaging Study (IBIS). Int. J. Cardiovasc. Intervent. 7, 52-58.
29. Tabas, I., Seimon, T., Timmins, J., Li, G., Lim, W. (2009) Macrophage apoptosis in advanced atherosclerosis. Ann. N. Y. Acad. Sci. 1173, E40-45.
30. Tavridou, A., Efthimiadis, A., Efthimiadis, I., Manolopoulos, V. G. (2010) Simvastatin-induced changes in circulating oxidized low-density lipoprotein in different types of dyslipidemia. Heart Vessels 25, 288-293.
31. Tesauro, M., Thompson, W. C., Rogliani, P., Qi, L., Chaudhary, P. P., Moss, J. (2000) Intracellular processing of endothelial nitric oxide synthase isoforms associated with differences in severity of cardiopulmonary diseases: cleavage of proteins with aspartate vs. glutamate at position 298. Proc. Natl. Acad. Sci. USA 6, 2832-2835.
32. Tomita, H., Egashira, K., Kubo-Inoue, M., Usui, M., Koyanagi, M., Shimokawa, H., Takeya, M., Yoshimura, T., Takeshita, A. (1998) Inhibition of NO synthesis induces inflammatory changes and monocyte chemoattractant protein-1 expression in rat hearts and vessels. Arterioscler. Thromb. Vasc. Biol. 18, 1456-1464.
33. Tsutsui, M., Shimokawa, H., Otsuji, Y., Yanagihara, N. (2010) Pathophysiological relevance of NO signaling in the cardiovascular system: novel insight from mice lacking all NO synthases. Pharmacol. Ther. 128, 499-508.
34. Veldman, B.A., Spiering, W., Doevendans, P. A., Vervoort, G., Kroon, A. A., de Leeuw, P. W., Smits, P. (2002) The Glu298Asp polymorphism of the NOS 3 gene as a determinant of the baseline production of nitric oxide. J. Hypertens. 20, 2023-2027.
35. Virmani, R., Burke, A. P., Farb, A., Kolodgie, F. D. (2006) Pathology of the vulnerable plaque. J. Am. Coll. Cardiol. 47, C13-18.
36. Wang, X. L., Sim, A. S., Wang, M. X., Murrell, G. A., Trudinger, B., Wang, J. (2000) Genotype dependent and cigarette specific effects on endothelial nitric oxide synthase gene expression and enzyme activity. FEBS Lett. 1, 45-50.
37. Wang, X. L., Wang, J. (2000) Endothelial nitric oxide synthase gene sequence variations and vascular disease. Mol. Genet. Metab. 70, 241-251.
38. Yachie, A., Niida, Y., Wada, T., Igarashi, N., Kaneda, H., Toma, T., Ohta, K., Kasahara, Y., Koizumi, S, (1999) Oxidative stress causes enhanced endothelial cell injury in human heme oxygenase-1 deficiency. J. Clin. Invest. 103, 129-135.
39. Yet, S. F., Layne, M. D., Liu, X., Chen, Y. H., Ith, B., Sibinga, N. E., Perrella, M. A. (2003) Absence of heme oxygenase-1 exacerbates atherosclerotic lesion formation and vascular remodeling. FASEB J. 17, 1759-1761.